bioMérieux S.A. (EPA:BIM)
France · Delayed Price · Currency is EUR 92.65
+0.85 (0.93%)
Apr 1, 2026, 9:44 AM CET
bioMérieux Revenue
In the year 2025, bioMérieux had annual revenue of 4.07B EUR with 2.26% growth. bioMérieux had revenue of 2.03B in the half year ending December 31, 2025, with 6.37% growth.
Revenue
4.07B
Revenue Growth
+2.26%
P/S Ratio
2.66
Revenue / Employee
273.25K
Employees
15,226
Market Cap
10.83B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 4.07B | 89.90M | 2.26% |
| Dec 31, 2024 | 3.98B | 305.20M | 8.31% |
| Dec 31, 2023 | 3.67B | 85.60M | 2.38% |
| Dec 31, 2022 | 3.59B | 212.90M | 6.31% |
| Dec 31, 2021 | 3.38B | 258.00M | 8.27% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Sanofi | 46.72B |
| EssilorLuxottica Société anonyme | 28.49B |
| Eurofins Scientific SE | 7.30B |
| emeis Société anonyme | 5.77B |
| Ramsay Générale de Santé | 5.32B |
| Clariane SE | 5.31B |
| Ipsen | 3.93B |
| Sartorius Stedim Biotech | 2.97B |